AI-Surgical Firm Carlsmed Seeks to Raise $107.2 Million in IPO

Carlsmed Inc., a medical technology company that uses AI to personalize spine surgery, is seeking to raise as much as $107.2 million in a US initial public offering.

The B Capital Group-backed firm plans to market 6.7 million shares for $14 to $16 each, according to its Tuesday filing with the US Securities and Exchange Commission.

At the top of the range, the medtech company would have a market value of about $424.3 million, based on the outstanding shares listed in the filing.

Carlsmed incurred a net loss of $5.7 million on revenue of $10.2 million for the ...